About
Wave Life Sciences LTD develops RNA-targeting therapeutics using chemistry innovation and human genetics insights aimed at treating rare and common diseases such as Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, Huntington’s disease, and obesity.
Explore Wave Life Sciences LTD's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.